Semaglutide for weight loss in obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- Your body mass index (BMI) is 30 or higher (considered obese).
- You have tried to lose weight through diet or exercise before, but it did not work.
- You have not taken any weight-loss or diabetes medications in the past 3 months.
- You have not had major weight changes (up or down more than 5% of your body weight) in the past 3 months.
- You are generally healthy, without serious heart, kidney, liver, or mental health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.
This study tests a weekly injection called semaglutide to see how well it helps people with obesity lose weight, compared to a similar approved medicine, Wegovy. It may be an option if you have struggled to lose weight in the past.
This trial tests a medicine called semaglutide (often used for diabetes) to see if it helps people in Bangladesh who are overweight or obese lose weight. The study will check if the medicine is safe and effective for both people with and without type 2 diabetes.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study looks at the experiences of people using injectable semaglutide for weight loss, as well as the doctors who prescribe it. It aims to understand how the treatment works in everyday life.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.